We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Levels of Inflammatory Markers in the Treatment of Stroke—An SPS3 Ancillary Study (LIMITS)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00579306
First Posted: December 24, 2007
Last Update Posted: July 24, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by (Responsible Party):
Mitchell S Elkind, Columbia University
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2012
  Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)